Vivid Wealth Management LLC Has $2.79 Million Position in Axon Enterprise, Inc $AXON

Vivid Wealth Management LLC lowered its position in Axon Enterprise, Inc (NASDAQ:AXON) by 18.6% during the second quarter, HoldingsChannel reports. The institutional investor owned 3,375 shares of the biotechnology company’s stock after selling 770 shares during the period. Vivid Wealth Management LLC’s holdings in Axon Enterprise were worth $2,794,000 as of its most recent SEC filing.

Other hedge funds have also recently added to or reduced their stakes in the company. TCI Wealth Advisors Inc. acquired a new position in Axon Enterprise in the second quarter worth approximately $214,000. Kentucky Retirement Systems Insurance Trust Fund acquired a new position in Axon Enterprise in the first quarter worth approximately $1,110,000. Quotient Wealth Partners LLC acquired a new position in Axon Enterprise in the first quarter worth approximately $438,000. CX Institutional acquired a new position in Axon Enterprise in the first quarter worth approximately $115,000. Finally, GAMMA Investing LLC increased its holdings in Axon Enterprise by 11.8% in the first quarter. GAMMA Investing LLC now owns 1,454 shares of the biotechnology company’s stock worth $765,000 after buying an additional 154 shares during the last quarter. Institutional investors and hedge funds own 79.08% of the company’s stock.

Axon Enterprise Stock Performance

Shares of NASDAQ AXON opened at $734.04 on Friday. The business has a fifty day simple moving average of $756.36 and a 200 day simple moving average of $711.76. The company has a current ratio of 2.95, a quick ratio of 2.71 and a debt-to-equity ratio of 0.63. The firm has a market capitalization of $57.63 billion, a price-to-earnings ratio of 181.24, a PEG ratio of 28.25 and a beta of 1.41. Axon Enterprise, Inc has a one year low of $422.38 and a one year high of $885.91.

Axon Enterprise (NASDAQ:AXON) last issued its earnings results on Monday, August 4th. The biotechnology company reported $2.12 EPS for the quarter, beating analysts’ consensus estimates of $1.54 by $0.58. The business had revenue of $668.54 million during the quarter, compared to analyst estimates of $641.77 million. Axon Enterprise had a return on equity of 6.80% and a net margin of 13.64%.Axon Enterprise’s revenue was up 32.6% on a year-over-year basis. During the same period in the prior year, the company posted $1.20 earnings per share. Axon Enterprise has set its FY 2025 guidance at EPS. Sell-side analysts expect that Axon Enterprise, Inc will post 5.8 EPS for the current year.

Insiders Place Their Bets

In related news, insider Jeffrey C. Kunins sold 7,891 shares of the company’s stock in a transaction on Thursday, August 14th. The stock was sold at an average price of $750.10, for a total value of $5,919,039.10. Following the completion of the transaction, the insider directly owned 144,538 shares in the company, valued at approximately $108,417,953.80. This represents a 5.18% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CEO Patrick W. Smith sold 10,000 shares of the company’s stock in a transaction on Monday, August 11th. The shares were sold at an average price of $831.29, for a total value of $8,312,900.00. Following the completion of the transaction, the chief executive officer owned 3,053,982 shares of the company’s stock, valued at $2,538,744,696.78. The trade was a 0.33% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 59,932 shares of company stock valued at $45,115,616 in the last ninety days. 4.40% of the stock is currently owned by insiders.

Analysts Set New Price Targets

A number of equities research analysts have issued reports on the company. Bank of America upped their target price on Axon Enterprise from $895.00 to $1,000.00 and gave the stock a “buy” rating in a research report on Wednesday, August 6th. Raymond James Financial reaffirmed an “outperform” rating and set a $855.00 target price (up previously from $645.00) on shares of Axon Enterprise in a research report on Tuesday, August 5th. UBS Group reaffirmed a “neutral” rating and set a $840.00 target price (up previously from $820.00) on shares of Axon Enterprise in a research report on Tuesday, August 5th. JPMorgan Chase & Co. upped their target price on Axon Enterprise from $730.00 to $850.00 and gave the stock an “overweight” rating in a research report on Thursday, July 17th. Finally, JMP Securities reaffirmed a “market outperform” rating and set a $825.00 target price on shares of Axon Enterprise in a research report on Monday, September 29th. Fourteen investment analysts have rated the stock with a Buy rating and four have given a Hold rating to the company’s stock. According to MarketBeat.com, Axon Enterprise currently has an average rating of “Moderate Buy” and a consensus price target of $841.64.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.